Lifevantage Corporation (NASDAQ:LFVN - Get Free Report)'s stock price crossed below its two hundred day moving average during trading on Monday. The stock has a two hundred day moving average of $6.20 and traded as low as $5.94. Lifevantage shares last traded at $5.98, with a volume of 26,980 shares changing hands.
Analyst Upgrades and Downgrades
LFVN has been the topic of a number of analyst reports. Lake Street Capital lifted their price objective on shares of Lifevantage from $5.00 to $6.00 and gave the company a "hold" rating in a research note on Friday, August 28th. Weiss Ratings restated a "hold (c)" rating on shares of Lifevantage in a research note on Friday, August 21st. Two analysts have rated the stock with a Hold rating. Based on data from MarketBeat, Lifevantage currently has an average rating of "Hold" and an average target price of $5.50.
Check Out Our Latest Report on Lifevantage
Lifevantage Trading Down 0.3%
The business's 50-day simple moving average is $6.28 and its two-hundred day simple moving average is $6.20. The company has a market capitalization of $75.29 million, a PE ratio of 14.95 and a beta of 0.68.
Lifevantage (NASDAQ:LFVN - Get Free Report) last announced its earnings results on Thursday, August 27th. The company reported $0.11 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.12 by ($0.01). Lifevantage had a return on equity of 21.56% and a net margin of 2.78%. The business had revenue of $42.38 million for the quarter, compared to analysts' expectations of $44.00 million. On average, analysts forecast that Lifevantage Corporation will post 0.39 EPS for the current year.
Lifevantage Announces Dividend
The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, September 15th. Shareholders of record on Tuesday, September 1st were paid a dividend of $0.05 per share. This represents a $0.20 dividend on an annualized basis and a yield of 3.3%. The ex-dividend date was Tuesday, September 1st. Lifevantage's dividend payout ratio (DPR) is 50.00%.
Insiders Place Their Bets
In other Lifevantage news, insider Kristen Cunningham sold 8,901 shares of Lifevantage stock in a transaction that occurred on Monday, September 14th. The stock was sold at an average price of $6.18, for a total transaction of $55,008.18. Following the sale, the insider directly owned 120,162 shares in the company, valued at $742,601.16. The trade was a 6.90% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. 13.58% of the stock is currently owned by company insiders.
Hedge Funds Weigh In On Lifevantage
Institutional investors have recently made changes to their positions in the business. Bank of New York Mellon Corp grew its position in shares of Lifevantage by 11.9% during the first quarter. Bank of New York Mellon Corp now owns 33,547 shares of the company's stock worth $145,000 after buying an additional 3,571 shares in the last quarter. Engineers Gate Manager LP increased its stake in shares of Lifevantage by 109.7% in the second quarter. Engineers Gate Manager LP now owns 27,009 shares of the company's stock worth $169,000 after buying an additional 14,131 shares during the last quarter. Bank of America Corp DE increased its stake in shares of Lifevantage by 24.3% in the first quarter. Bank of America Corp DE now owns 23,445 shares of the company's stock worth $101,000 after buying an additional 4,586 shares during the last quarter. Hsbc Holdings PLC acquired a new stake in Lifevantage in the first quarter valued at $51,000. Finally, DGS Capital Management LLC acquired a new stake in Lifevantage in the first quarter valued at $44,000. 35.32% of the stock is owned by institutional investors and hedge funds.
About Lifevantage
(
Get Free Report)
LifeVantage Corporation is a health and wellness company that develops, markets and distributes nutritional supplements, skincare products and other wellness solutions. Its products are designed to support areas such as cellular health, energy, healthy aging and skin care.
The company's product portfolio has included the Protandim line of dietary supplements, TrueScience skincare products and AXIO energy and wellness products. LifeVantage sells primarily through a direct-selling model, supported by independent distributors, as well as through digital commerce and other retail channels.
Founded in 2003 and headquartered in Lehi, Utah, LifeVantage serves customers in the United States and selected international markets, including Japan, Australia and Hong Kong.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Lifevantage, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Lifevantage wasn't on the list.
While Lifevantage currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.